Purity isn’t a marketing number — it’s the difference between a clean, reproducible result and a contaminated dataset. Here’s what ≥99% purity actually means, and why it matters for every experiment.
Why Purity Is the Foundation of Every Result
In peptide research, purity isn’t a cosmetic specification — it’s the variable that determines whether an experiment produces a trustworthy result at all. A compound that is only 90% pure carries an unknown 10% of byproducts, degradation fragments, or synthesis residue that can interfere with receptor binding assays, mass spectrometry readings, and cellular studies. When researchers see a batch rated at ≥99% purity, they’re looking at a compound where the vast majority of what’s in the vial is the actual peptide sequence they intended to study — not a collection of unpredictable variables.
How Purity Is Actually Measured
Purity claims are only as good as the method used to verify them. Two techniques form the backbone of peptide quality control:
High-Performance Liquid Chromatography (HPLC) separates a sample into its individual components based on how they interact with a stationary phase, producing a chromatogram where each peak represents a distinct compound. A clean, single dominant peak is the visual signature of a high-purity batch.
Mass Spectrometry (MS) confirms molecular identity by measuring the mass-to-charge ratio of ionized molecules, verifying that the peptide’s actual molecular weight matches its expected structure. Where HPLC tells you how pure a sample is, MS tells you that it’s the right molecule in the first place.
Used together, these two methods give researchers both purity percentage and identity confirmation — the two pieces of information every Certificate of Analysis (COA) should report.
What a Certificate of Analysis Should Include
A proper COA isn’t just a purity percentage on a page. It should document the batch or lot number, the testing method used, the date of analysis, and ideally a reference to the specific instrument or laboratory that performed the test. This level of documentation is what allows a batch to be traced back to its origin if a question ever arises about a specific result.
The Cost of Cutting Corners
Lower-purity compounds aren’t just less effective — they can actively mislead. A binding assay run against a peptide with unknown contaminants may show activity that doesn’t actually belong to the peptide under study, or may mask a genuine effect entirely. In a field where reproducibility is already a widely discussed challenge, starting with an unverified compound stacks the odds against a clean result before the experiment even begins.
What to Look for Before You Order
Researchers evaluating a peptide supplier should ask three questions: Is a COA provided for the specific batch being shipped, not just a generic product-level document? Was the testing performed by an independent third-party lab rather than self-reported? And is the purity threshold explicitly stated as a minimum, with the actual tested value available on request?
At BioFusion Peptides, every compound is manufactured and verified to a minimum ≥99% purity standard, with independent testing behind every batch. Documentation isn’t an afterthought — it’s built into how each product reaches the catalog in the first place.
All BioFusion Peptides products are supplied strictly for laboratory and in vitro research use. They are not for human or animal consumption.
